2026 NPPES data Optometrist NPI 1730563305 O.D.
Verify on CMS →

PALAK BUTALA, O.D.

Optometrist in TONAWANDA, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
194
Medicare Part D claims · 100 beneficiaries · Optometrist avg: 257
Generic prescribing
49%
generic claims · 51% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$245.69
2 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

PALAK BUTALA, O.D. filed 194 Medicare Part D claims in 2023 as a Optometrist in TONAWANDA, New York, prescribing 49% generic.

194
Part D claims, 2023
49%
generic prescribing
$245.69
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

PALAK BUTALA, O.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

194 35th percentile higher than 35% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about PALAK BUTALA, O.D.?

Quality data not reported

NPI registry status

Active

Issued 07/14/2015

NPI 1730563305

Primary specialty

Optometrist

High-volume

60,463 US NPIs in this specialty

Medicare Part D claims

194 25% vs specialty avg

2023 prescription claims

Specialty avg: 257

Specialty distribution in New York

How Optometrist compares to other specialties among New York providers

New York providers

Optometrist share within New York

1. Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Optometrist share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Optometrist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Optometrist ABMS/AOA estimate

Est. board-certified rate (Optometrist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Optometrist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

PALAK BUTALA, O.D. is a Optometrist provider practicing in TONAWANDA, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: O.D.. NPI: 1730563305. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

PALAK BUTALA, O.D. appears in the CMS NPPES registry as a Optometrist provider holding O.D. credentials at 2965 SHERIDAN DR, TONAWANDA, NY, 14150, with a listed phone of (716) 262-9297. NPI 1730563305 was issued on 07/14/2015. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BUTALA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 194 prescription claims written by this provider, covering 100 Medicare beneficiaries and totaling roughly $55K in drug spend, split 51% brand-name and 49% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2965 SHERIDAN DR
TONAWANDA, NY 14150

Provider Details

NPI 1730563305
Specialty Optometrist
Credentials O.D.
Gender Female
NPI Issued 07/14/2015

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for PALAK BUTALA, O.D.. Source: openpaymentsdata.cms.gov.

Total received

$246

Largest payer

Bausch & Lomb Americas Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to PALAK BUTALA, O.D.. To verify PALAK BUTALA, O.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

PALAK BUTALA, O.D. — brand share 51.0%
Specialty average (est.)

51% brand-name claims vs 49% generic, on 194 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

194
Total Claims
$55K
Total Drug Cost
100
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
320
Total Day Supply
8,747
Brand vs Generic
51% brand / 49% generic
Brand Drug Cost
$49K
Generic Drug Cost
$6K

Patient Demographics

Average Patient Age
72.5 years
Avg HCC Risk Score
1.13
Gender Split
74% female / 26% male
Age Distribution
<65: 15, 65-74: 46, 75-84: 26, 85+: 13

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
39
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
39
Cyclosporine
17
Prednisolone Acetate
17
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
11
Restasis
Cyclosporine
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Optometrist Overview

How PALAK BUTALA, O.D. fits within the Optometrist landscape nationally.

60,463
Optometrist Providers in US
56
States with Optometrist
257
Avg Claims per Provider

PALAK BUTALA, O.D.'s 194 claims are below the specialty average of 257.

Nearby Optometrist Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as BUTALA.

Compare Optometrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is PALAK BUTALA, O.D.'s specialty?
PALAK BUTALA, O.D. specializes in Optometrist and practices in TONAWANDA, New York. Credentials: O.D..
How much does PALAK BUTALA, O.D. prescribe under Medicare Part D?
In 2023, PALAK BUTALA, O.D. wrote 194 Medicare Part D claims totaling $55K in drug costs for 100 beneficiaries.
Where is PALAK BUTALA, O.D. located?
PALAK BUTALA, O.D. is located at 2965 SHERIDAN DR, TONAWANDA, NY, 14150. Phone: (716) 262-9297.
What is PALAK BUTALA, O.D.'s NPI number?
PALAK BUTALA, O.D.'s National Provider Identifier (NPI) is 1730563305, issued on 07/14/2015.
Does PALAK BUTALA, O.D. prescribe more brand-name or generic drugs?
PALAK BUTALA, O.D.'s prescribing is 51% brand-name and 49% generic drugs by claim count, with $49K in brand drug costs.
How many Optometrist providers are there in the US?
There are 60,463 Optometrist providers across 56 states in the US. The average Optometrist provider writes 257 Medicare Part D claims per year.
What drugs does PALAK BUTALA, O.D. prescribe most often?
Based on 2023 Medicare Part D data, PALAK BUTALA, O.D.'s most frequently prescribed drugs include Latanoprost, Neomycin-Polymyxin-Dexameth, Cyclosporine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does PALAK BUTALA, O.D. accept Medicare?
PALAK BUTALA, O.D. appears in CMS Medicare data with 194 Part D claims and 100 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify PALAK BUTALA, O.D.'s credentials?
PALAK BUTALA, O.D.'s NPI is 1730563305 with credentials O.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology